Something About Company
Gavi, the Vaccine Alliance, is a public-private partnership committed to saving children’s lives and protecting people’s health by increasing equitable use of vaccines in lower-income countries. The Vaccine Alliance brings together developing country and donor governments, the World Health Organisation, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Bill & Melinda Gates Foundation and other private sector partners. This is a complex alliance ecosystem. Gavi uses innovative finance mechanisms, including co-financing by recipient countries, to secure sustainable funding and adequate supply of quality vaccines. Gavi brings together the public and private sectors with the shared goal of creating equal access to new and underused vaccines for children living in the poorest countries.
Gavi is committed to working with their partners to protect the next generation and realise their mission to save lives, reduce poverty and protect the world against the threat of epidemics. Since 2000, Gavi has contributed to the immunisation of over 888 million children and the prevention of more than 15 million future deaths. At the Global Vaccine Summit in June 2020, world leaders pledged more than $8.8bn (exceeding their initial target) to ensure Gavi can continue to amplify this work and immunise another 300 million children by 2025.
Gavi is co-leading COVAX, the Covid Vaccine Delivery Programme, with the Coalition for Epidemic Preparedness Innovations (CEPI), UNICEF and the World Health Organisation (WHO), alongside key delivery partner UNICEF. Its aim is to accelerate the development and manufacture of COVID-19 vaccines, and to guarantee fair and equitable access for every country in the world, with emphasis on the developing economies for those most in need. As the pandemic emergency recedes COVAX will continue to be integrated into the core mission of Gavi.
In June 2019, the Gavi Board approved a new five-year strategy (“Gavi 5.0”) with a vision of “Leaving no one behind with immunisation”. This includes working within Gavi’s mission to save lives and protect people’s health by increasing equitable and sustainable use of vaccines. Gavi continues to drive towards this original mission. Building on successes of the previous strategic periods, Gavi 5.0 has several key shifts to deliver on its mission, including:
-
A core focus on reaching “zero-dose” children and missed communities, with equity as the organising principle
-
More differentiated, tailored and targeted approaches for Gavi-eligible countries
-
An increased focus on programmatic sustainability
-
Providing limited catalytic support for immunisation and select vaccine introduction in lower middle-income countries
Across all of its work, Gavi seeks to make missed communities, especially those within the implementing countries and developing economies, its priority.
While the Gavi Secretariat oversees the day-to-day operations of the Vaccine Alliance, the Board is responsible for giving strategic direction and policy-making. The Board oversees the operations of the Vaccine Alliance and monitors programme implementation.
The Board is comprised of 18 “representative” seats, 9 seats for independent or “unaffiliated” individuals and one seat for Gavi’s CEO. The Board’s representative seats ensure that institutions and constituencies can provide formal input into the development of all Gavi’s policies and the management of its operations.
UNICEF, WHO, the World Bank and the Bill & Melinda Gates Foundation hold permanent seats on the Board. Constituency representatives serve on a time-limited basis from both the public and private sector.
Independent Board members are private individuals with no professional connection to Gavi’s work. They bring independent and balanced scrutiny to all of the Board’s deliberations. These individuals also provide expertise in a number of critical areas such as investment, auditing and fundraising.
You can find further details on their website https://www.Gavi.org
